Proteomics analysis reveals diabetic kidney as a ketogenic organ in type 2 diabetes - PubMed (original) (raw)
. 2011 Feb;300(2):E287-95.
doi: 10.1152/ajpendo.00308.2010. Epub 2010 Oct 19.
Hang Yang, Xiaomu Kong, Kang Wang, Xuan Mao, Xianzhong Yan, Yuan Wang, Siqi Liu, Xiaoyan Zhang, Jing Li, Lihong Chen, Jing Wu, Mingfen Wei, Jichun Yang, Youfei Guan
Affiliations
- PMID: 20959534
- DOI: 10.1152/ajpendo.00308.2010
Free article
Proteomics analysis reveals diabetic kidney as a ketogenic organ in type 2 diabetes
Dongjuan Zhang et al. Am J Physiol Endocrinol Metab. 2011 Feb.
Free article
Abstract
Diabetic nephropathy (DN) is the leading cause of end-stage renal disease. To date, the molecular mechanisms of DN remain largely unclear. The present study aimed to identify and characterize novel proteins involved in the development of DN by a proteomic approach. Proteomic analysis revealed that 3-hydroxy-3-methylglutaryl-CoA (HMG-CoA) synthase 2 (HMGCS2), the key enzyme in ketogenesis, was increased fourfold in the kidneys of type 2 diabetic db/db mice. Consistently, the activity of HMGCS2 in kidneys and 24-h urinary excretion of the ketone body β-hydroxybutyrate (β-HB) were significantly increased in db/db mice. Immunohistochemistry, immunofluorescence, and real-time PCR studies further demonstrated that HMGCS2 was highly expressed in renal glomeruli of db/db mice, with weak expression in the kidneys of control mice. Because filtered ketone bodies are mainly reabsorbed in the proximal tubules, we used RPTC cells, a rat proximal tubule cell line, to examine the effect of the increased level of ketone bodies. Treating cultured RPTC cells with 1 mM β-HB significantly induced transforming growth factor-β1 expression, with a marked increase in collagen I expression. β-HB treatment also resulted in a marked increase in vimentin protein expression and a significant reduction in E-cadherin protein levels, suggesting an enhanced epithelial-to-mesenchymal transition in RPTCs. Collectively, these findings demonstrate that diabetic kidneys exhibit excess ketogenic activity resulting from increased HMGCS2 expression. Enhanced ketone body production in the diabetic kidney may represent a novel mechanism involved in the pathogenesis of DN.
Similar articles
- Meprin-alpha in chronic diabetic nephropathy: interaction with the renin-angiotensin axis.
Mathew R, Futterweit S, Valderrama E, Tarectecan AA, Bylander JE, Bond JS, Trachtman H. Mathew R, et al. Am J Physiol Renal Physiol. 2005 Oct;289(4):F911-21. doi: 10.1152/ajprenal.00037.2005. Epub 2005 Jun 7. Am J Physiol Renal Physiol. 2005. PMID: 15942051 - Combined therapy of rhein and benazepril on the treatment of diabetic nephropathy in db/db mice.
Jia ZH, Liu ZH, Zheng JM, Zeng CH, Li LS. Jia ZH, et al. Exp Clin Endocrinol Diabetes. 2007 Oct;115(9):571-6. doi: 10.1055/s-2007-981469. Exp Clin Endocrinol Diabetes. 2007. PMID: 17943690 - Endocannabinoids and the renal proximal tubule: an emerging role in diabetic nephropathy.
Jenkin KA, Verty AN, McAinch AJ, Hryciw DH. Jenkin KA, et al. Int J Biochem Cell Biol. 2012 Nov;44(11):2028-31. doi: 10.1016/j.biocel.2012.07.008. Epub 2012 Jul 27. Int J Biochem Cell Biol. 2012. PMID: 22842535 Review. - The pathogenesis of diabetic nephropathy: focus on microRNAs and proteomics.
Conserva F, Pontrelli P, Accetturo M, Gesualdo L. Conserva F, et al. J Nephrol. 2013 Sep-Oct;26(5):811-20. doi: 10.5301/jn.5000262. Epub 2013 Mar 27. J Nephrol. 2013. PMID: 23543479 Review.
Cited by
- Metabolic and Signaling Roles of Ketone Bodies in Health and Disease.
Puchalska P, Crawford PA. Puchalska P, et al. Annu Rev Nutr. 2021 Oct 11;41:49-77. doi: 10.1146/annurev-nutr-111120-111518. Annu Rev Nutr. 2021. PMID: 34633859 Free PMC article. - Proteomics and diabetic nephropathy: what have we learned from a decade of clinical proteomics studies?
Papale M, Di Paolo S, Vocino G, Rocchetti MT, Gesualdo L. Papale M, et al. J Nephrol. 2014 Jun;27(3):221-8. doi: 10.1007/s40620-014-0044-5. Epub 2014 Feb 25. J Nephrol. 2014. PMID: 24567069 Review. - Prostate cancer castrate resistant progression usage of non-canonical androgen receptor signaling and ketone body fuel.
Labanca E, Bizzotto J, Sanchis P, Anselmino N, Yang J, Shepherd PDA, Paez A, Antico-Arciuch V, Lage-Vickers S, Hoang AG, Tang X, Raso MG, Titus M, Efstathiou E, Cotignola J, Araujo J, Logothetis C, Vazquez E, Navone N, Gueron G. Labanca E, et al. Oncogene. 2021 Nov;40(44):6284-6298. doi: 10.1038/s41388-021-02008-9. Epub 2021 Sep 28. Oncogene. 2021. PMID: 34584218 Free PMC article. - Identification of Novel Key Molecular Signatures in the Pathogenesis of Experimental Diabetic Kidney Disease.
Diao M, Wu Y, Yang J, Liu C, Xu J, Jin H, Wang J, Zhang J, Gao F, Jin C, Tian H, Xu J, Ou Q, Li Y, Xu G, Lu L. Diao M, et al. Front Endocrinol (Lausanne). 2022 Mar 30;13:843721. doi: 10.3389/fendo.2022.843721. eCollection 2022. Front Endocrinol (Lausanne). 2022. PMID: 35432190 Free PMC article. - The Potential Roles of Artemisinin and Its Derivatives in the Treatment of Type 2 Diabetes Mellitus.
Jiang YY, Shui JC, Zhang BX, Chin JW, Yue RS. Jiang YY, et al. Front Pharmacol. 2020 Nov 26;11:585487. doi: 10.3389/fphar.2020.585487. eCollection 2020. Front Pharmacol. 2020. PMID: 33381036 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous